Researchers at Rensselaer Polytechnic Institute and the University of North Carolina, Chapel Hill, Announce New Method To Build Important Heparin Drug
In an effort to increase engagement with the public, surrounding business community, and Rensselaer community in the life-saving and high-tech research ongoing at the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer, a series of regular open sessions with Rensselaer researchers will begin on March 10. The first forum, “Making Medications Safer,” will begin with a light breakfast outside the CBIS Auditorium at 8 a.m. The new series will be called the Biotechnology Public Interest Forums.
Rensselaer Polytechnic Institute professor to present lessons from 2008 heparin deaths Saturday, Feb. 19 Robert J. Linhardt will discuss drug safety in an increasingly global economy during the 2011 AAAS Annual Meeting in Washington, D.C.